Kernebeck patent opposition analysis

The comprehensive analysis of Kernebeck opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Kernebeck

Patent NumberTitleApplicantOpposition DateOpposition Company
Sglt-2 Inhibitor For Treating Type 1 Diabetes Mellitus, Type 2 Diabete Mellitus, Impaired Glucose Tolerance Or HyperglycemiaBOEHRINGER INGELHEIM INTERNATIONAL GMBHAug 25, 2026STADA ARZNEIMITTEL
Antibody-Containing PreparationCHUGAI SEIYAKU KABUSHIKI KAISHAAug 19, 2026KERNEBECK PATENTANWALTS
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEONE MEDICINES I GMBHAug 5, 2026KERNEBECK PATENTANWALTS
Mavacamten For Use In The Treatment Of Hypertrophic CardiomyopathyMYOKARDIA, INC.Jun 17, 2026KERNEBECK PATENTANWALTS
Methods Of Treating Chronic Kidney Disease With DapagliflozinASTRAZENECA ABJun 17, 2026STADA ARZNEIMITTEL
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIM INTERNATIONAL GMBHSep 18, 2025STADA ARZNEIMITTEL
Cylodextrin Complexation Methods For Formulating Peptide Proteasome InhibitorsONYX THERAPEUTICS, INC.Jan 17, 2025STADA ARZNEIMITTEL
Apixaban FormulationsBRISTOL-MYERS SQUIBB COMPANYDec 19, 2024STADA ARZNEIMITTEL
Pharmaceutical Composition Comprising Glucopyranosyl Diphenylmethane Derivatives, Pharmaceutical Dosage Form Thereof, Process For Their Preparation And Uses Thereof For Improved Glycemic Control In A PatientBOEHRINGER INGELHEIM INTERNATIONAL GMBHOct 17, 2024STADA ARZNEIMITTEL
Use Of A Combination Comprising A Btk Inhibitor For Treating CancersBEIGENE SWITZERLAND GMBHSep 13, 2024KERNEBECK PATENTANWALTS

Top companies who are the clients of Kernebeck